Mr Omar Al Kadhi
Consultant Urological Surgeon
MBChB, PhD, FRCS(Urol)
I specialise in general urology and urological cancers with specialist interest in bladder cancer. I provide tests and treatments for bothersome urinary symptoms in men and women, prostate cancer, urinary tract infections, prostatitis, scrotal lumps and bumps, circumcision, endoscopic removal of bladder lesions and pharmacological treatments for erectile dysfunction.
I have been a consultant urological surgeon since 2018. To date I have performed over 250 open and robotic pelvic cancer procedures, and more than 750 endoscopic procedures including TURBT, TURP and cystoscopy. I have specialist experience in the surgical treatments of bladder cancer including endoscopic, open and robotic surgery.
I am the lead for urological cancer at the Norfolk & Norwich University Hospital. I chair the weekly specialist multi-disciplinary meeting for urological cancers. I was appointed as the cancer lead for urology at the Norfolk and Norwich University Hospitals in 2020.
I completed my senior urology training in Norwich and Cambridge and was awarded a PhD in prostate cancer from the University of East Anglia (UEA) in 2017. I completed a Fellowship in robotic prostatectomy and cystectomy in University College London Hospitals (UCLH), one of the highest volume centres for robotic urology in the UK.
Some of the principal treatments carried out by Mr Omar Al Kadhi at Spire include:
COVID-19 testing or antibody tests are not available as a standalone service at Spire Norwich Hospital.
MBChB / University of Baghdad / 2003
Bachelor of Medicine, Bachelor of Surgery
PhD Prostate Cancer / University of East Anglia, Norwich / 2017
Doctorate of Philosophy in Prostate Cancer
British Association of Urological Surgeon (BAUS)
European Association of Urology (EAU)
Royal College of Surgeons of England
British Medical Association (BMA)
Cancer lead for urology at the Norfolk & Norwich University Hospital
I am an invited peer-reviewer for the Journal of Urology and the BMC Urology.
Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes.
Transcriptional changes in prostate of men on active surveillance after a 12-mo glucoraphanin-rich broccoli intervention—results from the Effect of Sulforaphane on prostate CAncer PrEvention (ESCAPE) randomized controlled trial.
Increased transcriptional and metabolic capacity for lipid metabolism in the peripheral zone of the prostate may underpin its increased susceptibility to cancer
A renal colic fast-track pathway to improve waiting times and outcomes for patients presenting to the emergency department
Day case Holmium Laser Enucleation of the Prostate for all ages and all prostate sizes-Early experience with a defined day case pathway
Integrating transcriptome and metabolome signatures to provide new insights as to how diet can prevent prostate cancer progression
World-first approach to operation on cancer patient
When I am not at work I love spending my time with my family and exploring the countryside. I enjoy walking, cycling and following motor-sport.
|Telephone||01603 255 614|
|Private secretary||Cathy Smith|
|Private secretary telephone||01603 720 324|
|Private secretary firstname.lastname@example.org|